Company Filing History:
Years Active: 2009-2022
Title: The Innovative Contributions of Zhe Yang
Introduction
Zhe Yang is a prominent inventor based in Daly City, California, known for his significant contributions to the field of pharmaceuticals. With a total of 15 patents to his name, he has made remarkable strides in developing compounds that have the potential to enhance skeletal muscle function.
Latest Patents
Among his latest patents are the amino-pyrimidine skeletal muscle modulators. These patents detail compounds of Formula I, or pharmaceutically acceptable salts thereof, with specific structural components defined within the documentation. Additionally, the patents include pharmaceutically acceptable compositions comprising these compounds, as well as methods for their use in medical applications.
Career Highlights
Zhe Yang is currently associated with Cytokinetics, Inc., a company dedicated to discovering and developing innovative treatments for diseases related to muscle function. His work at Cytokinetics has positioned him as a key player in the advancement of therapeutic options for patients with muscle-related conditions.
Collaborations
Zhe Yang collaborates with notable colleagues such as Gustave Bergnes and Scott E Collibee, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Zhe Yang's contributions to the field of pharmaceuticals, particularly through his patents on amino-pyrimidine skeletal muscle modulators, highlight his role as an influential inventor. His work continues to pave the way for advancements in muscle-related therapies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.